TCTR20210627002招募中不适用
Efficacy of the Hemoperfusion Therapy in Patients with Severe COVID-19-Associated Pneumonia: An Experience from Single-center Observational Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Age >18 years, 2. Severe COVID-19-associated pneumonia with or without hemoperfusion therapy, 3. Admitted in Chiang Mai University Hospital, Chiang Mai, Thailand
排除标准
- 未提供
研究者
相似试验
招募中
2 期
Hemoperfusion in Covid 19IRCT20210718051922N1Shahre-kord University of Medical Sciences60
招募中
不适用
Hemoperfusion effect in treatment of patients with COVID-19IRCT20110425006280N12Vice President of Research Guilan university of medical sciences20
招募中
2 期
The role of hemoperfusion in COVID-19COVID-19.COVID-19U07.1IRCT20200608047686N2Shahid Beheshti University of Medical Sciences40
已完成
不适用
Clinical research for hemoperfusion therapy with an immobilized polymyxin B (PMX) fiber column in patients with severe influenza pneumonia in Vietnam and Japasevere influenza pneumoniaJPRN-UMIN000003669Disease Control and Prevention Center10
已完成
2 期
Hemoperfusion in patients with COVID-19IRCT20150704023055N2Babol University of Medical Sciences10